Skip to main content

Dr. Chris Palmer: The Ketogenic Diet in Neurology and Psychiatry

In this presentation for Low Carb Down Under, Dr. Chris Palmer explores the bridge between metabolism and mental health, highlighting how a medical ketogenic diet can treat "treatment-resistant" mental illnesses.

1. History and Medical Context [00:00:36]

The ketogenic diet was specifically formulated in the 1920s to treat epilepsy, a brain disorder. It mimics the fasting state, which has been known since antiquity to stop seizures. While anti-seizure medications became the standard in the 1950s, the diet remains a "gold standard" for patients who do not respond to drugs.

2. Variations of the Diet [00:02:45]

Dr. Palmer emphasizes that a "medical" ketogenic diet is different from a standard low-carb diet:

  • Classic Keto (4:1 or 3:1 ratio): 80-90% of calories come from fat.
  • Modified Atkins Diet (MAD): Often a 2:1 ratio; more palatable but still therapeutically effective for many [00:03:58].
  • Key Insight: This is a prescription-strength intervention, not necessarily a weight-loss tool [00:06:33].

3. How Keto Affects the Brain [00:12:20]

The diet works through multiple mechanisms:

  • Alternative Fuel: Provides ketones when the brain has "glucose hypometabolism."
  • Neurotransmitters: Balances GABA and glutamate levels.
  • Mitochondrial Health: Increases the number and efficiency of mitochondria [00:13:25].
  • Reduced Inflammation: Lowers brain inflammation and changes gene expression.

Dr. Palmer presents evidence for a "bi-directional" relationship between mental disorders and metabolic diseases:

  • Obesity & Diabetes: Patients with schizophrenia and bipolar disorder are significantly more likely to develop metabolic syndrome before starting medications [00:24:47].
  • Life Expectancy: Mental illness reduces lifespan by 7–30 years, primarily due to metabolic issues like cardiovascular disease and diabetes, not just suicide [00:28:16].

5. Clinical Applications & Success Stories

  • Alcohol Use Disorder: NIH studies show keto reduces withdrawal symptoms and cravings [00:32:57].
  • Schizophrenia & Bipolar: Dr. Palmer shares the story of "Jane," a patient with chronic schizophrenia who achieved full remission and off-medication stability through a ketogenic diet [00:37:35].
  • Alzheimer’s: While it cannot resurrect dead neurons, pilot trials show improvement in "activities of daily living" and biomarkers [00:19:36].

6. Implementation Warning [00:43:49]

Dr. Palmer strongly advises against starting this for mental illness without professional supervision.

  • Keto-adaptation risks: Can cause temporary increases in anxiety, insomnia, or even suicidal ideation during the first few weeks.
  • Medication Management: Psychiatric meds (like Lithium or Antipsychotics) must be adjusted as the body's metabolism changes to avoid toxicity or relapses.

Conclusion [00:56:16]

The future of "Metabolic Psychiatry" is bright, with new clinical trials underway at institutions like Stanford. Dr. Palmer advocates for a shift from seeing mental illness as "incurable" to seeing it as a treatable metabolic dysfunction.